Aberrant PKM2 expression promotes malignant cellular transformation and is closely related to the clinical progression of solid tumors of the digestive system, including colorectal cancer, esophageal squamous cell carcinoma, oral cancer, biliary cancer, gastric cancer and hepatocellular carcinoma12, 13. The gene discussed is PKM; the disease is colorectal cancer.